Literature DB >> 11969337

The tumour suppressor gene maspin is differentially regulated in cytotrophoblasts during human placental development.

A Dokras1, L M G Gardner, D A Kirschmann, E A Seftor, M J C Hendrix.   

Abstract

Identification of factors that play a role in regulating the highly invasive ability of human placental cells throughout gestation will contribute to a better understanding of this unique developmental process. The aims of this study were to determine whether the tumour suppressor gene maspin is present in the human placenta and plays a putative role in the regulation of cytotrophoblast invasion during placental development. The data showed that the expression of maspin mRNA was maximum in term placentae compared to the first and second trimester tissues, and absent in the HTR-SVneo (immortalized extravillous cytotrophoblast), JEG-3 and JAR (choriocarcinoma) cell lines. Maspin protein, detected by Western blot analysis, was twofold higher in the second trimester and 4.4-fold higher in the third trimester compared to the first trimester. Maspin immunohistochemical staining was localized in cytotrophoblasts with increased and more diffuse staining in the second and third trimesters. Corresponding to the period of maximum maspin expression, cytotrophoblasts isolated from term placentae had significantly lower invasive ability as compared to first and second trimester cytotrophoblasts (P< 0.03). Further, addition of recombinant maspin significantly decreased cytotrophoblast invasion in vitro by 40-50 per cent in all three trimesters of gestation. This study provides the first evidence of the temporal expression of maspin during human gestation and suggests a putative role for maspin in regulating the invasive activity of cytotrophoblasts at term. The down-regulation of maspin expression may be critical at the time of implantation and early placental development, whereas upregulation of maspin may serve as a signal for the end of cytotrophoblast invasion and gestation. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11969337     DOI: 10.1053/plac.2001.0784

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  15 in total

1.  Aberrant methylation of the maspin promoter is an early event in human breast cancer.

Authors:  Bernard W Futscher; Megan M O'Meara; Christina J Kim; Margaret A Rennels; Di Lu; Lynn M Gruman; Richard E B Seftor; Mary J C Hendrix; Frederick E Domann
Journal:  Neoplasia       Date:  2004 Jul-Aug       Impact factor: 5.715

2.  Expression of maspin in the early pregnant mouse endometrium and its role during embryonic implantation.

Authors:  Yan Huang; Lu-Wei Cai; Rong Yang
Journal:  Comp Med       Date:  2012-06       Impact factor: 0.982

3.  Detection of the placental epigenetic signature of the maspin gene in maternal plasma.

Authors:  Stephen S C Chim; Yu K Tong; Rossa W K Chiu; Tze K Lau; Tse N Leung; Lisa Y S Chan; Cees B M Oudejans; Chunming Ding; Y M Dennis Lo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-03       Impact factor: 11.205

4.  Identification of differentially expressed genes in mouse hepatocarcinoma ascites cell line with low potential of lymphogenous metastasis.

Authors:  Xiao-Nan Cui; Jian-Wu Tang; Li Hou; Bo Song; Li-Ying Ban
Journal:  World J Gastroenterol       Date:  2006-11-14       Impact factor: 5.742

5.  Development of a survival prediction model for gastric cancer using serine proteases and their inhibitors.

Authors:  Ke-Feng Lei; Bing-Ya Liu; Xiao-Qing Zhang; Xiao-Long Jin; Yan Guo; Min Ye; Zheng-Gang Zhu
Journal:  Exp Ther Med       Date:  2011-09-21       Impact factor: 2.447

6.  Effect of epigenetic modification of maspin on extravillous trophoblastic function.

Authors:  Xinwei Shi; Yuanyuan Wu; Haiyi Liu; Xun Gong; Hui Du; Yuqi Li; Jun Zhao; Ping Chen; Guiju Tang; Fuyuan Qiao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-12-28

7.  Prognostic value of nuclear maspin expression for adjuvant 5-fluorouracil-based chemotherapy in advanced gastric cancer.

Authors:  Ke-Feng Lei; Bing-Ya Liu; Xiao-Long Jin; Yan Guo; Min Ye; Zheng-Gang Zhu
Journal:  Exp Ther Med       Date:  2012-03-30       Impact factor: 2.447

Review 8.  Maspin: the new frontier.

Authors:  Zhila Khalkhali-Ellis
Journal:  Clin Cancer Res       Date:  2006-12-15       Impact factor: 12.531

9.  Maternal decidual macrophages inhibit NK cell killing of invasive cytotrophoblasts during human pregnancy.

Authors:  Elizabeth C Co; Matthew Gormley; Mirhan Kapidzic; David B Rosen; Marvin A Scott; Haley A R Stolp; Michael McMaster; Lewis L Lanier; Alicia Bárcena; Susan J Fisher
Journal:  Biol Reprod       Date:  2013-06-20       Impact factor: 4.285

Review 10.  The placenta: phenotypic and epigenetic modifications induced by Assisted Reproductive Technologies throughout pregnancy.

Authors:  Cécile Choux; Virginie Carmignac; Céline Bruno; Paul Sagot; Daniel Vaiman; Patricia Fauque
Journal:  Clin Epigenetics       Date:  2015-08-21       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.